Perspectum Lands Top Spot in Alantra Pharma Fast 50 Rankings. Read more
Investor Director & Board Member
Tom Hawes is a member of the BlueCross BlueShield Fund Management team at Sandbox Industries and serves on the Sandbox Management Committee. He is the Board Chairman for Patientco, serves on the Board of Directors of Perspectum, Octave Bioscience, Upward Health, Oncology Analytics, Verata Health and AbleTo and is a board observer of Healthify and Thrive. Tom is a former board member of Phreesia (NYSE), Nexidia (NICE), Heartflow, and InVivoLink (HCA).
Before joining Sandbox, Tom matched at Yale School of Medicine for residency and completed his first year of medical training at Greenwich Hospital. During his medical training, he worked on clinical studies at the ISK Institute for Orthopaedics and Sports Medicine and on outcomes research at the National Cancer Institute and NYMC’s Cardiothoracic Surgery Department. Tom holds a BA from Brigham Young University, an M.D. from New York Medical College and an MBA from Harvard Business School. He is also a Kauffman Fellow.